StockComparison Logo
vs

SER vs BEAT

Comparison between AgeX Therapeutics Inc (SER, Company) and HeartBeam Inc (BEAT, Company).

Both SER and BEAT are from the Healthcare sector.

5-Year PerformanceBEAT has outperformed SER, delivering a return of -32.7% compared to -47.6%

SER vs BEAT - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
SER
$31M
BEAT
$31M
Max Drawdown
SER
99.35%
Winner
BEAT
90.19%
Sharpe Ratio
SER
-0.22
Winner
BEAT
0.18
5Y Beta
Winner
SER
0.28
BEAT
1.34
Industry
SER
Biotechnology
BEAT
Health Information Services
P/E Ratio
SER
-1.14
Winner
BEAT
-1.39
PEG Ratio
SER
-0.00
BEAT
N/A
5Y EPS CAGR
SER
-28.62%
BEAT
N/A
Debt to Equity
SER
0.00%
BEAT
0.00%
Free Cash Flow Yield
SER
-58.44%
Winner
BEAT
-44.70%

SER vs BEAT - Historical Returns

Returns include dividend reinvestment.

1M
Winner
SER
+39.07%
BEAT
-20.82%
3M
Winner
SER
+64.06%
BEAT
-39.71%
6M
Winner
SER
-20.96%
BEAT
-71.97%
1Y
SER
-63.48%
Winner
BEAT
-51.92%
5Y(CAGR)
SER
-47.62%
Winner
BEAT
-32.68%
Max(CAGR)
SER
-39.79%
Winner
BEAT
-32.68%

SER vs BEAT - Annual Returns (2018 - 2026)

Returns include dividend reinvestment.

YearSERBEAT
2026+1.06%-68.74%
2025-62.49%+2.13%
2024-66.51%-1.29%
2023-31.13%-48.91%
2022-41.91%+32.97%
2021-31.01%-34.33%
2020-22.05%N/A
2019-39.33%N/A
2018+10.33%N/A

SER vs BEAT Drawdown Comparison

The maximum drawdown for SER was -99.35%, occurring on Mar 18, 2026. This drawdown has not yet recovered.

The maximum drawdown for BEAT was -90.19%, occurring on Nov 25, 2025. This drawdown has not yet recovered.

The current SER drawdown is -98.93%. The current BEAT drawdown is -87.21%.

RankSERBEAT
#1-99.35%
Dec 3, 2018 - Mar 18, 2026
-90.19%
Dec 13, 2022 - Nov 25, 2025
#2N/A-74.84%
Nov 11, 2021 - Oct 6, 2022
#3N/A-50.17%
Oct 7, 2022 - Dec 8, 2022
#4N/A-5.64%
Dec 8, 2022 - Dec 13, 2022

Correlation

Correlation between SER and BEAT is 0.37 which considered as a weak positive correlation - the stocks show a slight tendency to move together.

0.37
-101

Select Stocks to Compare